We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01544049
Recruitment Status : Active, not recruiting
First Posted : March 5, 2012
Last Update Posted : October 26, 2017
Information provided by (Responsible Party):
Elizabeth Swisher, University of Washington

Brief Summary:
The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.

Condition or disease
Ovarian Cancer

Detailed Description:
Women will be found eligible for this study after an eligibility questionnaire given over the phone. If one is found eligible, she will be sent a consent and paper survey to fill out and send back to the research coordinator. Once that is completed, she will be given a phone interview in order answer additional questions of interest. Lastly, the study participant will be contacted once a year over the phone to obtain follow-up information.

Study Type : Observational
Actual Enrollment : 24 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Patients Salpingectomy as a Method of Ovarian Cancer Prevention: A Descriptive Study
Study Start Date : December 2011
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ovarian Cancer
U.S. FDA Resources

Fallopian tube removal
Women who have had one or both fallopian tube(s) removed as method of ovarian cancer prevention.

Primary Outcome Measures :
  1. Describe subject experience in undergoing Salpingectomy as a means of riks reduction [ Time Frame: At conclusion of study ]
    Subjects will provide information on their reason for choosing salpingectomy and the process they went through in undergoing this procedure

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 100 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women who have had their fallopian tubes removed as a method of ovarian cancer prevention.

Inclusion Criteria:

  • Female of at least 18 years of age
  • Must speak English fluently
  • Have had fallopian tubes removed as a method of ovarian cancer prevention

Exclusion Criteria:

  • Males
  • Females under the age of 18

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01544049

United States, Washington
University of Washington
Seattle, Washington, United States, 98195
Sponsors and Collaborators
University of Washington
Principal Investigator: Elizabeth Swisher, MD University of Washington

Responsible Party: Elizabeth Swisher, Professor, University of Washington
ClinicalTrials.gov Identifier: NCT01544049     History of Changes
Other Study ID Numbers: STUDY00000276
First Posted: March 5, 2012    Key Record Dates
Last Update Posted: October 26, 2017
Last Verified: October 2017

Keywords provided by Elizabeth Swisher, University of Washington:
fallopian tube removal
ovarian cancer prevention

Additional relevant MeSH terms:
Ovarian Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders